Lowenstein Reps BASF In Deal For Biotech Co. Verenium

Law360, New York (September 20, 2013, 4:30 PM EDT) -- Chemical company BASF Corp. will acquire industrial biotechnology company Verenium Corp., which serves the global food and fuel industries, for about $4 per share, the companies said Friday.

Verenium has about 12.8 million shares outstanding, which would value the deal at about $51 million. The deal is expected to close in the fourth quarter of 2013. The acquisition will bolster BASF’s role in the efficient enzyme space, according to a statement issued by BASF.

“Combining Verenium’s scientific and technological excellence with BASF’s enzyme activities and its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.